Publication | Open Access

Metronomic trofosfamide inhibits progression of human lung cancer xenografts by exerting anti-angiogenic effects

Tumor BiologyMetronomic TrofosfamideMedicineMetronomic TherapyPharmacologyAnti-angiogenic EffectsBronchial NeoplasmPharmacotherapyAnti-cancer AgentMetronomic ChemotherapyCancer TreatmentOncologyRadiation OncologyLung CancerCancer Research